sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
XENE
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals Inc. | Buy | $559,740 | Kelly Thomas Patrick Chief Financial Officer | 15,000 sh | at $37.32 | Filed Oct 1, 9:20 AM ET | Filing | |
| XENE Xenon Pharmaceuticals Inc. | Buy | $1,121,400 | MORTIMER IAN PRESIDENT & CEO, Director | 30,000 sh | at $37.38 | Filed Oct 1, 9:19 AM ET | Filing | |
| XENE Xenon Pharmaceuticals Inc. | Sale | $425,829 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 7,068 sh | at $60.25 | Filed Aug 31, 9:59 PM ET | Filing | |
| XENE Xenon Pharmaceuticals Inc. | Sale | $640,550 | GANNON STEVEN Director | 10,000 sh | at $64.06 | Filed Aug 13, 4:33 PM ET | Filing |